Article
Impact of KRAS mutation on response and outcome of patients with stage III non-squamous non-small cell lung cancer.
Cancer science - 1 Oct 2015
Yagishita Shigehiro, Horinouchi Hidehito, Sunami Kuniko S, Kanda Shintaro, Fujiwara Yutaka, Nokihara Hiroshi, Yamamoto Noboru, Sumi Minako, Shiraishi Kouya, Kohno Takashi, Furuta Koh, Tsuta Koji, Tamura Tomohide, Ohe Yuichiro
Abstract excerpt
The frequency and clinical profile of patients with stage III non-small cell lung cancer harboring KRAS mutations have not yet been well documented. Here, we analyzed hotspot KRAS mutations using high-resolution melting analyses in tumor specimens from patients who received chemoradiotherapy between January 2001 and December 2010 at the National Cancer Center Hospital. The associations between the presence of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
